Total Payments
$26,475
2024 Payments
$1,391
Companies
39
Transactions
256
Medicare Patients
13,811
Medicare Billing
$2.4M
Payment Breakdown by Category
Consulting$16,970 (64.1%)
Food & Beverage$3,502 (13.2%)
Other$3,038 (11.5%)
Travel$2,653 (10.0%)
Education$312.42 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,970 | 10 | 64.1% |
| Food and Beverage | $3,502 | 213 | 13.2% |
| Travel and Lodging | $2,653 | 14 | 10.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,206 | 6 | 8.3% |
| Long term medical supply or device loan | $681.53 | 7 | 2.6% |
| Education | $312.42 | 5 | 1.2% |
| Honoraria | $150.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $9,104 | 16 | $0 (2018) |
| Shire North American Group Inc | $6,120 | 16 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $1,956 | 4 | $0 (2024) |
| Celgene Corporation | $1,616 | 11 | $0 (2023) |
| TG THERAPEUTICS, INC. | $1,526 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,505 | 63 | $0 (2024) |
| AbbVie, Inc. | $926.74 | 7 | $0 (2019) |
| GlaxoSmithKline, LLC. | $568.38 | 3 | $0 (2024) |
| Genentech USA, Inc. | $329.65 | 34 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $312.52 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,391 | 17 | Novartis Pharmaceuticals Corporation ($756.56) |
| 2023 | $1,758 | 6 | AstraZeneca Pharmaceuticals LP ($1,388) |
| 2022 | $379.91 | 7 | Alexion Pharmaceuticals, Inc. ($250.00) |
| 2021 | $1,651 | 2 | TG THERAPEUTICS, INC. ($1,526) |
| 2020 | $1,999 | 4 | Celgene Corporation ($1,413) |
| 2019 | $1,290 | 30 | AbbVie, Inc. ($844.41) |
| 2018 | $4,013 | 60 | Pharmacyclics LLC, An AbbVie Company ($3,019) |
| 2017 | $13,992 | 130 | Shire North American Group Inc ($6,107) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 05/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.35 | General |
| 03/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Oncology | ||||||
| 02/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Oncology | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.44 | General |
| 01/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/08/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Travel and Lodging | In-kind items and services | $143.60 | General |
| Category: HEMATOLOGY | ||||||
| 08/07/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,387.50 | General |
| 07/31/2023 | SOBI, INC | Doptelet (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/16/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Oncology | ||||||
| 04/18/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $85.95 | General |
| 01/18/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| Category: Hematology | ||||||
| 12/19/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Hematology | ||||||
| 12/15/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,791 | 61,924 | $2.2M | $493,843 |
| 2022 | 42 | 3,559 | 92,125 | $4.4M | $1.1M |
| 2021 | 40 | 3,640 | 67,136 | $1.7M | $467,027 |
| 2020 | 37 | 2,821 | 37,467 | $1.2M | $309,577 |
Total Patients
13,811
Total Services
258,652
Medicare Billing
$2.4M
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 431 | 1,495 | $619,550 | $165,961 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 491 | $276,570 | $78,321 | 28.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 32 | 6,100 | $177,400 | $35,547 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 167 | 167 | $125,710 | $31,870 | 25.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 36 | 252 | $172,620 | $31,844 | 18.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 602 | 2,219 | $70,105 | $18,623 | 26.6% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 35 | 40,800 | $204,000 | $16,283 | 8.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 547 | 1,792 | $62,720 | $13,631 | 21.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 190 | $72,200 | $13,260 | 18.4% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 16 | 1,900 | $57,000 | $12,011 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 146 | $41,860 | $11,823 | 28.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 62 | 184 | $61,640 | $11,229 | 18.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 369 | 885 | $38,245 | $9,160 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $21,315 | $5,208 | 24.4% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 31 | 32 | $27,520 | $5,179 | 18.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 75 | 375 | $24,030 | $4,812 | 20.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 29 | 301 | $24,080 | $4,422 | 18.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 143 | 266 | $17,290 | $3,554 | 20.6% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 69 | 176 | $14,820 | $3,270 | 22.1% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 20 | 117 | $17,550 | $3,182 | 18.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 231 | 412 | $10,300 | $2,612 | 25.4% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 38 | 205 | $21,300 | $2,491 | 11.7% |
| 83550 | Iron binding capacity | Office | 2023 | 137 | 258 | $12,900 | $2,211 | 17.1% |
| 83540 | Iron level | Office | 2023 | 137 | 258 | $7,740 | $1,636 | 21.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 83 | 94 | $6,580 | $1,389 | 21.1% |
About Dr. Joseph Ramek, M.D
Dr. Joseph Ramek, M.D is a Specialist healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992880090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Ramek, M.D has received a total of $26,475 in payments from pharmaceutical and medical device companies, with $1,391 received in 2024. These payments were reported across 256 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($16,970).
As a Medicare-enrolled provider, Ramek has provided services to 13,811 Medicare beneficiaries, totaling 258,652 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location New Hyde Park, NY
- Active Since 10/26/2006
- Last Updated 08/19/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1992880090
Products in Payments
- Imbruvica (Drug) $9,104
- REBLOZYL (Biological) $1,428
- Venclexta (Drug) $903.99
- KISQALI (Drug) $889.11
- IMFINZI (Biological) $525.00
- ZEJULA (Drug) $425.00
- ELITEK (Drug) $330.00
- OPDIVO (Biological) $280.61
- SIR-Spheres Microspheres (Device) $163.56
- JADENU (Drug) $154.70
- IMBRUVICA (Drug) $150.46
- Oral Paclitaxel (Drug) $150.00
- TECENTRIQ (Biological) $149.23
- MONOFERRIC (Drug) $143.60
- XTANDI (Drug) $128.22
- Revlimid (Drug) $117.75
- KEYTRUDA (Biological) $115.82
- ZYTIGA (Drug) $113.02
- UNITUXIN (Drug) $100.00
- Doptelet (Drug) $99.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New Hyde Park
Dr. Elliott Salamon, Do, DO
Specialist — Payments: $52,956
Specialist $52,956
Dr. Andrew Porges, Md, MD
Specialist — Payments: $30,781
Specialist $30,781
Dr. Ivan Pavkovic, M.d, M.D
Specialist — Payments: $29,318
Specialist $29,318
Dr. Slavina Gardella, M.d, M.D
Specialist — Payments: $23,827
Specialist $23,827
Victor Katz, Md, MD
Specialist — Payments: $19,161
Specialist $19,161
Dr. Jeffrey Mallin, Md, MD
Specialist — Payments: $18,333
Specialist $18,333